Forward Pharma A/S FWP
Set alert
1.95 0.00 0.00%
At close · Dec 27
1.94 Day range 2.06
52-week range unavailable
- Open
- 1.94
- Prev close
- 1.95
- Mkt cap
- 13.83M
- Vol
- 43.35K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.94
- High
- 2.06
- Forward P/E
- -21.67
- Beta
- 1.38
- Short ratio
- 1.78
- Inst. own
- 12.90%
- Dividend
- 0.00
- Ex-div date
- Sep 11, 2017
- 50-d avg
- 2.76
- 200-d avg
- 4.01
- 1y target
- 0.00
Key statistics
- Market cap
- 13.83M
- Enterprise value
- -49.49M
- Trailing P/E
- 0.00
- Forward P/E
- -21.67
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.22
- EPS (TTM)
- -0.271
- Beta
- 1.38
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- -2.29M
- Total cash
- 65.28M
- Total debt
- 2.94M
- Return on equity
- -0.83%
- Shares outstanding
- 7.09M
- Short % of float
- 0.00%
- 50-day average
- 2.76
- 200-day average
- 4.01
Analyst view
Consensus: none
Price target (mean) 0.00
Ratings (0m) 2 0 buy · 2 hold · 0 sell
- Strong buy0
- Buy0
- Hold2
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate 0.00.
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 25, 2020 | JMP Securities | down | Market Outperform | Market Perform |
| Nov 25, 2020 | Jefferies | down | Buy | Hold |
| Nov 25, 2020 | JMP Securities | main | — | Market Outperform |
| Nov 25, 2020 | Leerink Swann | main | — | Outperform |
| Nov 25, 2020 | Jefferies | main | — | Buy |
| Nov 25, 2020 | Leerink Swann | main | — | Outperform |
About Forward Pharma A/S
Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. Forward Pharma A/S was incorporated in 2005 and is headquartered in Copenhagen, Denmark.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- Denmark
- Website
- forward-pharma.com
News
- Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session
- Stocks That Hit 52-Week Lows On Thursday
- Stocks That Hit 52-Week Lows On Friday
- Why is Forward Pharma Stock Plunging During Premarket Tuesday?
- FWP Stock: Over 20% Decrease Pre-Market Explanation
- Forward Pharma Announces the Decision of the Technical Board of Appeal of the European Patent Office in the EP2801355 Appeal Hearing
- Stocks That Hit 52-Week Highs On Tuesday
- Forward Pharma Reports Financial and Operational Results from the Year Ended December 31, 2020
- 80 Biggest Movers From Yesterday
- Forward Pharma Announces Rescheduling of the EP2801355 Appeal Hearing to September 6, 2021 due to COVID-19 Restrictions
Your note
Sign in to keep a note on FWP — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| BVF Inc. | 7.25% | 513,791 | 1.00M | Sep 29, 2022 |
| Morgan Stanley | 2.30% | 163,299 | 318.43K | Sep 29, 2022 |
| Mason Capital Management, LLC | 2.12% | 150,217 | 292.92K | Sep 29, 2022 |
| Acadian Asset Management. LLC | 0.87% | 61,468 | 119.86K | Sep 29, 2022 |
| Perigon Wealth Management, Llc | 0.26% | 18,124 | 35.34K | Sep 29, 2022 |
| UBS Group AG | 0.03% | 2,157 | 4.21K | Sep 29, 2022 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity NASDAQ Composite Index Fund | 0.07% | 4,735 | 9.23K | Oct 30, 2022 |